Intravenous Fluid Therapy (Crystalloids)

Treatment for Dengue

Typical Dosage: Initial 10-20 mL/kg bolus over 15-30 min, then maintenance 3-5 mL/kg/hr, guided by hemodynamics

Effectiveness
95%
Safety Score
65%
Clinical Trials
50
Participants
20K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
Initial 10-20 mL/kg bolus over 15-30 min, then maintenance 3-5 mL/kg/hr, guided by hemodynamics
Time to Effect
Immediate
Treatment Duration
12-72 hours
Evidence Quality
HIGH
Number Needed to Treat (NNT)
5(Treat 5 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
20(Treat 20 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$150
Monitoring:$8,000
Side Effect Mgmt:$500
Total Annual:$8,650
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$9,611.11
Intravenous Fluid Therapy (Crystalloids) Outcomes

for Dengue

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+90%
Common Side Effects
Fluid overload (pulmonary edema)
+8%
Electrolyte imbalance
+5%
Catheter-related infection
+1%

Sources:

nih.gov
clinmedjournals.org
paho.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov